Impel Pharmaceuticals gets OK sell assets to stalking horse JN BidCo

By Sarah Lizee

Olympia, Wash., Feb. 2 – Impel Pharmaceuticals Inc. received approval to sell its assets to stalking horse bidder JN BidCo LLC, according to a minute entry filed Thursday with the U.S. Bankruptcy Court for the Northern District of Texas.

The company said it did not receive any qualified bids by the deadline, as previously reported.

The proposed purchase price under the stalking horse agreement is $17.5 million.

Impel Pharmaceuticals is a commercial-stage pharmaceutical company. The company filed bankruptcy on Dec. 19 under Chapter 11 case number 23-80016.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.